시장보고서
상품코드
1701107

세계의 바이오센서 시장 규모, 점유율, 성장 분석 : 유형별, 제품별, 기술별, 컴포넌트별, 용도별, 지역별 - 산업 예측(2025-2032년)

Biosensors Market Size, Share, and Growth Analysis, By Type (Sensor Patch, Embedded Device), By Product (Wearable Biosensors, Non-Wearable Biosensors), By Technology, By Component, By Application, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이오센서 2023년 시장 규모는 302억 7,000만 달러, 2024년 327억 2,000만 달러에서 2032년 610억 2,000만 달러로 성장할 것으로 예상되며, 예측기간(2025-2032년) 동안 8.1%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.

바이오센서 시장은 당뇨병, 심혈관 질환과 같은 만성질환이 전 세계적으로 증가함에 따라 괄목할 만한 성장세를 보이고 있습니다. 이러한 분석기는 세포, 조직, 효소가 관여하는 생체 반응을 전기 신호로 변환하여 환경 모니터링, 식량 안보, 생물의학 연구를 촉진합니다. 인구 증가는 병원과 약국에서 의료 진단 도구에 대한 수요를 증가시키고 있습니다. 또한, 바이오센서가 탑재된 진단 기기의 보급으로 신속하고 정확한 질병 진단이 가능해져 환자 치료도 개선되고 있습니다. 첨단 바이오센서 플랫폼을 개발하기 위해 반도체 기업과 의료기기 기업이 제휴하는 추세는 시장 확대를 더욱 가속화하고 있습니다. 조기 진단과 개인 맞춤형 의료에 대한 관심이 높아짐에 따라 바이오센서 시장은 지속적인 개척과 혁신이 이루어질 태세를 갖추고 있습니다.

목차

서론

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 전제조건과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porter의 Five Forces 분석

주요 시장 인사이트

  • 중요 성공 요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 사례 연구
  • 기술 진보
  • 규제 상황
  • 특허 분석

바이오센서 시장 규모 : 유형별

  • 시장 개요
  • 센서 패치
  • 임베디드 디바이스

바이오센서 시장 규모 : 제품별

  • 시장 개요
  • 웨어러블 바이오센서
    • 리스트웨어
    • 아이웨어
    • 신발
    • 넥웨어
    • 바디웨어
    • 기타
  • 비웨어러블 바이오센서

바이오센서 시장 규모 : 기술별

  • 시장 개요
  • 전기화학 바이오센서
    • 안류계 센서
    • 전위차계 센서
    • 전도 비율 센서
  • 광학 바이오센서
    • SPR
    • 색채 측정 바이오센서
    • 형광 바이오센서
  • 압전 바이오센서
    • 음향 바이오센서
    • 마이크로 캔틸레버 바이오센서
  • 서멀 바이오센서
  • 나노 메커니컬 바이오센서

바이오센서 시장 규모 : 컴포넌트별

  • 시장 개요
  • 바이오 리셉터 분자
  • 생물학적 요소
  • 트랜스듀서

바이오센서 시장 규모 : 용도별

  • 시장 개요
  • Poc
    • 혈당 모니터링
    • 심장 마커
    • 감염증 모니터링
    • 응고 모니터링
    • 임신 검사
    • 혈액가스 및 전해질 감지
    • 종양 또는 암마커 감지
    • 소변검사
    • 콜레스테롤 검사
  • 홈 진단
    • 혈당 모니터링
    • 임신 검사
    • 콜레스테롤 검사
  • 연구실
  • 환경 모니터링
  • 식품 및 음료
  • 바이오 디펜스

바이오센서 시장 규모

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 최근 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업 개요
    • 기업 상세
    • 제품 포트폴리오 분석
    • 기업 부문별 점유율 분석
    • 매출 전년대비 비교(2022-2024년)

주요 기업 개요

  • Abbott Laboratories(USA)
  • Roche Diagnostics(Switzerland)
  • Medtronic plc(Ireland)
  • Bio-Rad Laboratories, Inc.(USA)
  • DuPont(USA)
  • Biosensors International Group, Ltd.(Singapore)
  • Cytiva(UK)
  • Dexcom, Inc.(USA)
  • Lifescan IP Holdings, LLC(USA)
  • Masimo Corporation(USA)
  • Nova Biomedical(USA)
  • Universal Biosensors(Australia)
  • ACON Laboratories, Inc.(USA)
  • CARDEA BIO INC.(USA)
  • Conductive Technologies(USA)
  • EarlySense(Israel)
  • Innovative Sensor Technology IST AG(Switzerland)
  • LifeSignals(USA)
  • NeuroSky(USA)
  • SD Biosensor, INC.(South Korea)

결론과 제안

LSH 25.05.21

Biosensors Market size was valued at USD 30.27 billion in 2023 and is poised to grow from USD 32.72 billion in 2024 to USD 61.02 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The biosensor market is witnessing significant growth due to rising chronic diseases like diabetes and cardiovascular issues globally. These analytical devices convert biological reactions involving cells, tissues, and enzymes into electrical signals, facilitating environmental monitoring, food security, and biomedical research. The increasing population has elevated the demand for medical diagnostic tools in hospitals and pharmacies. Furthermore, the proliferation of diagnostic devices featuring biosensors enables rapid and accurate disease diagnosis, enhancing patient care. The trend of collaborations between semiconductor and medical device companies to develop advanced biosensor platforms is further accelerating market expansion. As the emphasis on early diagnosis and personalized medicine grows, the biosensor market is poised for continued development and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biosensors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biosensors Market Segments Analysis

Global Biosensors Market is segmented by Type, Product, Technology, Component, Application and region. Based on Type, the market is segmented into Sensor Patch and Embedded Device. Based on Product, the market is segmented into Wearable Biosensors and Non-Wearable Biosensors. Based on Technology, the market is segmented into Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors and Nanomechanical Biosensors. Based on Component, the market is segmented into Bioreceptor Molecules, Biological Element and Transducer. Based on Application, the market is segmented into Poc, Home Diagnostics, Research Labs, Environmental Monitoring, Food & Beverages and Biodefense. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biosensors Market

The biosensors market is propelled by the increasing demand for point-of-care (POC) assays, particularly within the healthcare sector. These innovative devices facilitate quick, precise, and portable testing, which is crucial for tracking chronic illnesses, handling urgent health issues, and addressing public health crises. The effectiveness of POC testing has spurred its implementation across diverse environments, ranging from clinical facilities to home care settings, significantly contributing to the expansion of the biosensors market. This rising trend reflects a broader shift towards more accessible healthcare solutions that enhance patient outcomes and streamline medical responses.

Restraints in the Biosensors Market

A significant constraint in the biosensors market is the elevated cost linked to the development of sophisticated biosensors. The creation and production of highly sensitive and precise biosensors typically require costly materials and intricate manufacturing techniques. Such expenses can hinder widespread adoption, particularly in resource-constrained settings and developing regions, where affordability plays a crucial role in implementation. Consequently, these financial challenges may limit the accessibility of advanced biosensing technologies to a broader audience, impeding market growth and innovation in areas that could greatly benefit from these advancements in healthcare and diagnostics.

Market Trends of the Biosensors Market

The biosensors market is witnessing a significant trend driven by the rising deployment of devices for diabetes monitoring. As diabetes prevalence escalates globally, there is a growing demand for early diagnosis and continuous surveillance of the disease. Biosensors offer superior advantages, including accurate insulin estimation and cost-effectiveness, making them essential for effective management and treatment efficacy in diabetic patients. Traditional methods of insulin detection are often time-consuming and lack real-time monitoring capabilities, presenting an opportunity for biosensors to enhance patient care. This shift towards innovative, reliable, and quicker diagnostic solutions is propelling the biosensors market towards substantial growth in the healthcare sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape
  • Patent Analysis

Global Biosensors Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Sensor Patch
  • Embedded Device

Global Biosensors Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Wearable Biosensors
    • Wristwear
    • Eyewear
    • Footwear
    • Neckwear
    • Bodywear
    • Others
  • Non-Wearable Biosensors

Global Biosensors Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Electrochemical Biosensors
    • Amperometric Sensors
    • Potentiometric Sensors
    • Conductometric Sensors
  • Optical Biosensors
    • SPR
    • Colorimetric Biosensors
    • Fluorescence Biosensors
  • Piezoelectric Biosensors
    • Acoustic Biosensors
    • Microcantilever Biosensors
  • Thermal Biosensors
  • Nanomechanical Biosensors

Global Biosensors Market Size by Component & CAGR (2025-2032)

  • Market Overview
  • Bioreceptor Molecules
  • Biological Element
  • Transducer

Global Biosensors Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Poc
    • Glucose Monitoring
    • Cardiac Marker
    • Infectious Disease Detection
    • Coagulation Monitoring
    • Pregnancy Testing
    • Blood Gas & Electrolyte Detection
    • Detection Of Tumor Or Cancer Marker
    • Urinalysis Testing
    • Cholesterol Testing
  • Home Diagnostics
    • Glucose Monitoring
    • Pregnancy Testing
    • Cholesterol Testing
  • Research Labs
  • Environmental Monitoring
  • Food & Beverages
  • Biodefense

Global Biosensors Market Size & CAGR (2025-2032)

  • North America (Type, Product, Technology, Component, Application)
    • US
    • Canada
  • Europe (Type, Product, Technology, Component, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Product, Technology, Component, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Product, Technology, Component, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Product, Technology, Component, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DuPont (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biosensors International Group, Ltd. (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cytiva (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dexcom, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifescan IP Holdings, LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Masimo Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nova Biomedical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Universal Biosensors (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ACON Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CARDEA BIO INC. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Conductive Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EarlySense (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Innovative Sensor Technology IST AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeSignals (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuroSky (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SD Biosensor, INC. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제